Treatment is recommended for all patients exhibiting clinical signs of hypothyroidism, TSH levels ≥10 mIU/L, or with goiter, infertility, and strong anti-TPO antibodies, even with subclinical hypothyroidism and TSH <10 mIU/L [9,10]. The gene discussed is TPO; the disease is hypothyroidism.